Globus Medical, Inc. (NYSE:GMED) Q3 2024 Earnings Call Transcript
Operator: Welcome to Globus Medical's Third Quarter 2024 Earnings Call. At this time, all lines will be on mute and a Q&A session will be held after the prepared remarks.
Globus Medical Inc (GMED)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sculptor Capital Daniel S. Och | 2,210,738 | $158,156,197 | 2.69% | |
| 2. | Hawk Ridge Management David Brown | 2,177,417 | $155,772,412 | -9% | 6.72% |
| 3. | Citadel Investment Group Ken Griffin | 1,586,624 | $113,507,081 | +104% | 0.02% |
| 4. | Magnetar Capital Alec Litowitz And Ross Laser | 1,433,422 | $102,547,010 | -17% | 2.22% |
| 5. | Parsifal Capital Management David Zorub | 1,350,553 | $96,618,562 | +51% | 6.6% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $53.88 | 615 | Director | 2,005 | 2020-08-24 | Filing | |
| $47.75 | 690 | Director | 1,390 | 2020-07-22 | Filing | |
| $48.20 | 700 | Director | 700 | 2020-06-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $80.02 | 60,000 | 0 | 2024-11-06 | Filing | ||
| $82.00 | 2,500 | 0 | 2024-11-06 | Filing | ||
| $80.02 | 2,500 | 2,500 | 2024-11-06 | Filing | ||
| $75.02 | 7,500 | 0 | 2024-10-16 | Filing | ||
| $75.03 | 20,000 | 185,967 | 2024-10-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,277,722 | $600,989,805 | 0.01% | |
| 2. | 10,842,057 | $577,773,218 | 0.01% | |
| 3. | 7,908,828 | $421,461,730 | 0.25% | |
| 4. | 3,539,020 | $188,594,376 | 0% | |
| 5. | 2,912,454 | $155,204,674 | 0.02% |
News See All
8 Most Promising Medical Stocks According to Hedge Funds
The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, and treatment.
Globus Medical, Inc. (NYSE:GMED) Q2 2024 Earnings Call Transcript
Operator: Welcome to Globus Medical's Second Quarter 2024 Earnings Call. At this time, all lines will be on mute and a Q&A session will be held after the prepared remarks.
Globus Medical, Inc. (NYSE:GMED) Q1 2024 Earnings Call Transcript
Globus Medical, Inc. beats earnings expectations. Reported EPS is $0.72, expectations were $0.55. Globus Medical, Inc.
11 Best Small-Cap Growth Stocks to Invest In
In this piece, we will take a look at the 11 best small-cap growth stocks to invest in.
Globus Medical, Inc. (NYSE:GMED) Q4 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Globus Medical’s Fourth Quarter and Full Year 2023 Earnings Call. [Operator Instructions].
Globus Medical, Inc. (NYSE:GMED) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Globus Medical Third Quarter 2023 Earnings Call. [Operator Instructions].
15 Worst Performing Healthcare Stocks in 2023
In this article, we discuss 15 worst performing healthcare stocks in 2023.
Globus Medical, Inc. (NYSE:GMED) Q2 2023 Earnings Call Transcript
Operator: Welcome to Globus Medical's Second Quarter 2023 Earnings Call. At this time, all lines will be on mute and a Q&A session will be held after the prepared remarks.
Globus Medical (GMED) Declined on Investors’ Concerns Over Merger
Madison Investments, an investment advisor, released its “Madison Small Cap Fund” first-quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
